Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection.

Paul FeuerstadtCaterina OnetoGlenn S TillotsonNicholas W Van Hise

Published in: Patient preference and adherence (2023)

LBP-recipients and LBP-naïve subjects alike felt that rectal delivery of microbiome therapy is not only acceptable but highly interesting as a treatment avenue.

Keyphrases

clostridium difficile
rectal cancer
case report
stem cells
combination therapy
bone marrow
mesenchymal stem cells
replacement therapy